These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37956676)

  • 1. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
    Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
    J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.
    Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
    Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
    J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers.
    Adnan M; Koli S; Mohammad T; Siddiqui AJ; Patel M; Alshammari N; Bardakci F; Elasbali AM; Hassan MI
    OMICS; 2022 Aug; 26(8):461-470. PubMed ID: 35925819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations.
    Singh P; Kumar V; Jung TS; Lee JS; Lee KW; Hong JC
    J Mol Model; 2024 Jul; 30(8):267. PubMed ID: 39012568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enriching Anticancer Drug Pipeline with Potential Inhibitors of Cyclin-Dependent Kinase-8 Identified from Natural Products.
    Zehra ; Hussain A; AlAjmi MF; Ishrat R; Hassan MI
    OMICS; 2024 Sep; 28(9):478-488. PubMed ID: 39149808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
    Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
    Tesser-Gamba F; Lopes LJ; Petrilli AS; Toledo SR
    Mol Carcinog; 2016 Nov; 55(11):1700-1713. PubMed ID: 26460937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel
    Elasbali AM; Al-Soud WA; Elfaki EM; Alanazi HH; Alharbi B; Alharethi SH; Anwer K; Mohammad T; Hassan MI
    J Biomol Struct Dyn; 2024 Jul; 42(11):5982-5994. PubMed ID: 37403288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based virtual screening and molecular dynamics simulation for the identification of sphingosine kinase-2 inhibitors as potential analgesics.
    Akhilesh ; Baidya ATK; Uniyal A; Das B; Kumar R; Tiwari V
    J Biomol Struct Dyn; 2022; 40(23):12472-12490. PubMed ID: 34519252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of allosteric inhibitor against AKT1 through structure-based virtual screening.
    Karunakaran K; Muniyan R
    Mol Divers; 2023 Dec; 27(6):2803-2822. PubMed ID: 36522517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.
    Shahroz MM; Sharma HK; Altamimi ASA; Alamri MA; Ali A; Ali A; Alqahtani S; Altharawi A; Alabbas AB; Alossaimi MA; Riadi Y; Firoz A; Afzal O
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35208955
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Alshehri SA; Wahab S; Almoyad MAA
    J Biomol Struct Dyn; 2024 Nov; 42(18):9463-9474. PubMed ID: 37643015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling effective extracellular signal-regulated kinase 2 inhibitors: a
    Hassan HA; Muhammed SS; Al-Khdhairawi A; Abdelwahab SF; Abdel-Rahman IM; Abdelhamid MM
    J Biomol Struct Dyn; 2024 Sep; 42(15):7906-7916. PubMed ID: 37584104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
    Alotaibi BS; Joshi J; Hasan MR; Khan MS; Alharethi SH; Mohammad T; Alhumaydhi FA; Elasbali AM; Hassan MI
    J Biomol Struct Dyn; 2023; 41(14):6749-6758. PubMed ID: 35965440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.